Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Harmonization study between three laboratories for expression of malaria vaccine clinical trial IgG antibody ELISA data in µg/mL.

Labbé GM, Miura K, Silk SE, Gu W, Moon JE, Jin J, Payne RO, Fay MP, Dutta S, Long CA, Draper SJ.

Malar J. 2019 Sep 2;18(1):300. doi: 10.1186/s12936-019-2935-3.

2.

Proactive community case management and child survival: protocol for a cluster randomised controlled trial.

Whidden C, Treleaven E, Liu J, Padian N, Poudiougou B, Bautista-Arredondo S, Fay MP, Samaké S, Cissé AB, Diakité D, Keita Y, Johnson AD, Kayentao K.

BMJ Open. 2019 Aug 26;9(8):e027487. doi: 10.1136/bmjopen-2018-027487.

3.

Strong concordance between percent inhibition in oocyst and sporozoite intensities in a Plasmodium falciparum standard membrane-feeding assay.

Miura K, Swihart BJ, Deng B, Zhou L, Pham TP, Diouf A, Fay MP, Long CA.

Parasit Vectors. 2019 May 6;12(1):206. doi: 10.1186/s13071-019-3470-3.

4.

Benralizumab for PDGFRA-Negative Hypereosinophilic Syndrome.

Kuang FL, Legrand F, Makiya M, Ware J, Wetzler L, Brown T, Magee T, Piligian B, Yoon P, Ellis JH, Sun X, Panch SR, Powers A, Alao H, Kumar S, Quezado M, Yan L, Lee N, Kolbeck R, Newbold P, Goldman M, Fay MP, Khoury P, Maric I, Klion AD.

N Engl J Med. 2019 Apr 4;380(14):1336-1346. doi: 10.1056/NEJMoa1812185.

PMID:
30943337
5.

Malaria parasite clearance rate regression: an R software package for a Bayesian hierarchical regression model.

Sharifi-Malvajerdi S, Zhu F, Fogarty CB, Fay MP, Fairhurst RM, Flegg JA, Stepniewska K, Small DS.

Malar J. 2019 Jan 5;18(1):4. doi: 10.1186/s12936-018-2631-8.

6.

The PAGODAS protocol: pediatric assessment group of dengue and Aedes saliva protocol to investigate vector-borne determinants of Aedes-transmitted arboviral infections in Cambodia.

Manning JE, Oliveira F, Parker DM, Amaratunga C, Kong D, Man S, Sreng S, Lay S, Nang K, Kimsan S, Sokha L, Kamhawi S, Fay MP, Suon S, Ruhl P, Ackerman H, Huy R, Wellems TE, Valenzuela JG, Leang R.

Parasit Vectors. 2018 Dec 20;11(1):664. doi: 10.1186/s13071-018-3224-7.

7.

Artemisinin resistance phenotypes and K13 inheritance in a Plasmodium falciparum cross and Aotus model.

Sá JM, Kaslow SR, Krause MA, Melendez-Muniz VA, Salzman RE, Kite WA, Zhang M, Moraes Barros RR, Mu J, Han PK, Mershon JP, Figan CE, Caleon RL, Rahman RS, Gibson TJ, Amaratunga C, Nishiguchi EP, Breglio KF, Engels TM, Velmurugan S, Ricklefs S, Straimer J, Gnädig NF, Deng B, Liu A, Diouf A, Miura K, Tullo GS, Eastman RT, Chakravarty S, James ER, Udenze K, Li S, Sturdevant DE, Gwadz RW, Porcella SF, Long CA, Fidock DA, Thomas ML, Fay MP, Sim BKL, Hoffman SL, Adams JH, Fairhurst RM, Su XZ, Wellems TE.

Proc Natl Acad Sci U S A. 2018 Dec 4;115(49):12513-12518. doi: 10.1073/pnas.1813386115. Epub 2018 Nov 19.

8.

Development of standard clinical endpoints for use in dengue interventional trials: introduction and methodology.

Jaenisch T, Hendrickx K, Erpicum M, Agulto L, Tomashek KM, Dempsey W, Siqueira JB, Marks MA, Fay MP, Laughlin C, L'Azou M, Leo YS, Narvaez F, Teyssou R, Thomas SJ, Tissera H, Wallace D, Wilder-Smith A, Gubler DJ, Cassetti MC.

BMC Med Res Methodol. 2018 Nov 15;18(1):134. doi: 10.1186/s12874-018-0601-z.

9.

Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adults.

Sagara I, Healy SA, Assadou MH, Gabriel EE, Kone M, Sissoko K, Tembine I, Guindo MA, Doucoure M, Niaré K, Dolo A, Rausch KM, Narum DL, Jones DL, MacDonald NJ, Zhu D, Mohan R, Muratova O, Baber I, Coulibaly MB, Fay MP, Anderson C, Wu Y, Traore SF, Doumbo OK, Duffy PE.

Lancet Infect Dis. 2018 Sep;18(9):969-982. doi: 10.1016/S1473-3099(18)30344-X. Epub 2018 Jul 27.

10.

Confidence intervals of the Mann-Whitney parameter that are compatible with the Wilcoxon-Mann-Whitney test.

Fay MP, Malinovsky Y.

Stat Med. 2018 Nov 30;37(27):3991-4006. doi: 10.1002/sim.7890. Epub 2018 Jul 8.

PMID:
29984411
11.

Response to letter by Antonio Martín Andrés on "A boundary-optimized rejection region test for the two-sample binomial problem".

Gabriel EE, Nason M, Fay MP, Follmann D.

Stat Med. 2018 Jun 30;37(14):2303-2306. doi: 10.1002/sim.7684. No abstract available.

PMID:
29864228
12.

Large-scale Artemisinin-Piperaquine Mass Drug Administration With or Without Primaquine Dramatically Reduces Malaria in a Highly Endemic Region of Africa.

Deng C, Huang B, Wang Q, Wu W, Zheng S, Zhang H, Li D, Feng D, Li G, Xue L, Yang T, Tuo F, Mohadji F, Su XZ, Xu Q, Wu Z, Lin L, Zhou J, Yan H, Bacar A, Said Abdallah K, Kéké RA, Msa Mliva A, Mohamed M, Wang X, Huang S, Oithik F, Li XB, Lu F, Fay MP, Liu XH, Wellems TE, Song J.

Clin Infect Dis. 2018 Nov 13;67(11):1670-1676. doi: 10.1093/cid/ciy364.

13.

Causal estimands and confidence intervals associated with Wilcoxon-Mann-Whitney tests in randomized experiments.

Fay MP, Brittain EH, Shih JH, Follmann DA, Gabriel EE.

Stat Med. 2018 Sep 10;37(20):2923-2937. doi: 10.1002/sim.7799. Epub 2018 May 17.

14.

Long-Term Clinical Outcomes of High-Dose Mepolizumab Treatment for Hypereosinophilic Syndrome.

Kuang FL, Fay MP, Ware J, Wetzler L, Holland-Thomas N, Brown T, Ortega H, Steinfeld J, Khoury P, Klion AD.

J Allergy Clin Immunol Pract. 2018 Sep - Oct;6(5):1518-1527.e5. doi: 10.1016/j.jaip.2018.04.033. Epub 2018 May 8.

15.

Dexpramipexole as an oral steroid-sparing agent in hypereosinophilic syndromes.

Panch SR, Bozik ME, Brown T, Makiya M, Prussin C, Archibald DG, Hebrank GT, Sullivan M, Sun X, Wetzler L, Ware J, Fay MP, Dunbar CE, Dworetzky SI, Khoury P, Maric I, Klion AD.

Blood. 2018 Aug 2;132(5):501-509. doi: 10.1182/blood-2018-02-835330. Epub 2018 May 8. Erratum in: Blood. 2018 Sep 27;132(13):1461.

16.

Statistical Methods for Standard Membrane-Feeding Assays to Measure Transmission Blocking or Reducing Activity in Malaria.

Swihart BJ, Fay MP, Miura K.

J Am Stat Assoc. 2018;113(522):534-545. doi: 10.1080/01621459.2017.1356313. Epub 2018 Jun 12.

17.

A boundary-optimized rejection region test for the two-sample binomial problem.

Gabriel EE, Nason M, Fay MP, Follmann DA.

Stat Med. 2018 Mar 30;37(7):1047-1058. doi: 10.1002/sim.7579. Epub 2017 Dec 26.

PMID:
29280170
18.

Measuring precision in bioassays: Rethinking assay validation.

Fay MP, Sachs MC, Miura K.

Stat Med. 2018 Feb 20;37(4):519-529. doi: 10.1002/sim.7528. Epub 2017 Oct 19.

19.

Insights Into Onchocerca volvulus Population Biology Through Multilocus Immunophenotyping.

Norice-Tra CT, Ribeiro J, Bennuru S, Fay MP, Tyagi R, Mitreva M, Nutman TB.

J Infect Dis. 2017 Sep 15;216(6):736-743. doi: 10.1093/infdis/jix394.

20.

Hypereosinophilic Syndrome Subtype Predicts Responsiveness to Glucocorticoids.

Khoury P, Abiodun AO, Holland-Thomas N, Fay MP, Klion AD.

J Allergy Clin Immunol Pract. 2018 Jan - Feb;6(1):190-195. doi: 10.1016/j.jaip.2017.06.006. Epub 2017 Jul 27.

21.

Posttreatment Reactions After Single-Dose Diethylcarbamazine or Ivermectin in Subjects With Loa loa Infection.

Herrick JA, Legrand F, Gounoue R, Nchinda G, Montavon C, Bopda J, Tchana SM, Ondigui BE, Nguluwe K, Fay MP, Makiya M, Metenou S, Nutman TB, Kamgno J, Klion AD.

Clin Infect Dis. 2017 Apr 15;64(8):1017-1025. doi: 10.1093/cid/cix016.

22.

Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial.

Sissoko MS, Healy SA, Katile A, Omaswa F, Zaidi I, Gabriel EE, Kamate B, Samake Y, Guindo MA, Dolo A, Niangaly A, Niaré K, Zeguime A, Sissoko K, Diallo H, Thera I, Ding K, Fay MP, O'Connell EM, Nutman TB, Wong-Madden S, Murshedkar T, Ruben AJ, Li M, Abebe Y, Manoj A, Gunasekera A, Chakravarty S, Sim BKL, Billingsley PF, James ER, Walther M, Richie TL, Hoffman SL, Doumbo O, Duffy PE.

Lancet Infect Dis. 2017 May;17(5):498-509. doi: 10.1016/S1473-3099(17)30104-4. Epub 2017 Feb 16.

PMID:
28216244
23.

Pearson's chi-square test and rank correlation inferences for clustered data.

Shih JH, Fay MP.

Biometrics. 2017 Sep;73(3):822-834. doi: 10.1111/biom.12653. Epub 2017 Feb 9.

PMID:
28182832
24.

Confidence intervals for directly standardized rates using mid-p gamma intervals.

Fay MP, Kim S.

Biom J. 2017 Mar;59(2):377-387. doi: 10.1002/bimj.201600111. Epub 2016 Dec 23.

PMID:
28008645
25.

Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults.

Talaat KR, Ellis RD, Hurd J, Hentrich A, Gabriel E, Hynes NA, Rausch KM, Zhu D, Muratova O, Herrera R, Anderson C, Jones D, Aebig J, Brockley S, MacDonald NJ, Wang X, Fay MP, Healy SA, Durbin AP, Narum DL, Wu Y, Duffy PE.

PLoS One. 2016 Oct 17;11(10):e0163144. doi: 10.1371/journal.pone.0163144. eCollection 2016.

26.

Non-inferiority tests for anti-infective drugs using control group quantiles.

Fay MP, Follmann DA.

Clin Trials. 2016 Dec;13(6):632-640. Epub 2016 Jul 17.

27.

Transmission-blocking activity is determined by transmission-reducing activity and number of control oocysts in Plasmodium falciparum standard membrane-feeding assay.

Miura K, Swihart BJ, Deng B, Zhou L, Pham TP, Diouf A, Burton T, Fay MP, Long CA.

Vaccine. 2016 Jul 29;34(35):4145-4151. doi: 10.1016/j.vaccine.2016.06.066. Epub 2016 Jun 29.

28.

A rank test for bivariate time-to-event outcomes when one event is a surrogate.

Shaw PA, Fay MP.

Stat Med. 2016 Aug 30;35(19):3413-23. doi: 10.1002/sim.6950. Epub 2016 Apr 5.

29.

Molecular Epidemiology of Blood-Borne Human Parasites in a Loa loa-, Mansonella perstans-, and Plasmodium falciparum-Endemic Region of Cameroon.

Drame PM, Montavon C, Pion SD, Kubofcik J, Fay MP, Nutman TB.

Am J Trop Med Hyg. 2016 Jun 1;94(6):1301-1308. doi: 10.4269/ajtmh.15-0746. Epub 2016 Apr 4.

30.

Maternal Helminth Infection Is Associated With Higher Infant Immunoglobulin A Titers to Antigen in Orally Administered Vaccines.

Clark CE, Fay MP, Chico ME, Sandoval CA, Vaca MG, Boyd A, Cooper PJ, Nutman TB.

J Infect Dis. 2016 Jun 15;213(12):1996-2004. doi: 10.1093/infdis/jiw066. Epub 2016 Feb 16.

31.

Finite sample pointwise confidence intervals for a survival distribution with right-censored data.

Fay MP, Brittain EH.

Stat Med. 2016 Jul 20;35(16):2726-40. doi: 10.1002/sim.6905. Epub 2016 Feb 18. Review.

32.

Clinical features predict responsiveness to imatinib in platelet-derived growth factor receptor-alpha-negative hypereosinophilic syndrome.

Khoury P, Desmond R, Pabon A, Holland-Thomas N, Ware JM, Arthur DC, Kurlander R, Fay MP, Maric I, Klion AD.

Allergy. 2016 Jun;71(6):803-10. doi: 10.1111/all.12843. Epub 2016 Mar 2.

33.

Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study.

Amaratunga C, Lim P, Suon S, Sreng S, Mao S, Sopha C, Sam B, Dek D, Try V, Amato R, Blessborn D, Song L, Tullo GS, Fay MP, Anderson JM, Tarning J, Fairhurst RM.

Lancet Infect Dis. 2016 Mar;16(3):357-65. doi: 10.1016/S1473-3099(15)00487-9. Epub 2016 Jan 8.

34.

Corrigendum: Artemisinin-resistant Plasmodium falciparum clinical isolates can infect diverse mosquito vectors of Southeast Asia and Africa.

St Laurent B, Miller B, Burton TA, Amaratunga C, Men S, Sovannaroth S, Fay MP, Miotto O, Gwadz RW, Anderson JM, Fairhurst RM.

Nat Commun. 2016 Jan 8;7:10345. doi: 10.1038/ncomms10345. No abstract available.

35.

Effect of red blood cell variants on childhood malaria in Mali: a prospective cohort study.

Lopera-Mesa TM, Doumbia S, Konaté D, Anderson JM, Doumbouya M, Keita AS, Diakité SA, Traoré K, Krause MA, Diouf A, Moretz SE, Tullo GS, Miura K, Gu W, Fay MP, Taylor SM, Long CA, Diakité M, Fairhurst RM.

Lancet Haematol. 2015 Apr;2(4):e140-9. doi: 10.1016/S2352-3026(15)00043-5. Epub 2015 Mar 24.

36.

Artemisinin-resistant Plasmodium falciparum clinical isolates can infect diverse mosquito vectors of Southeast Asia and Africa.

St Laurent B, Miller B, Burton TA, Amaratunga C, Men S, Sovannaroth S, Fay MP, Miotto O, Gwadz RW, Anderson JM, Fairhurst RM.

Nat Commun. 2015 Oct 20;6:8614. doi: 10.1038/ncomms9614. Erratum in: Nat Commun. 2016;7:10345.

37.

Standardization of the antibody-dependent respiratory burst assay with human neutrophils and Plasmodium falciparum malaria.

Llewellyn D, Miura K, Fay MP, Williams AR, Murungi LM, Shi J, Hodgson SH, Douglas AD, Osier FH, Fairhurst RM, Diakite M, Pleass RJ, Long CA, Draper SJ.

Sci Rep. 2015 Sep 16;5:14081. doi: 10.1038/srep14081.

38.

Bayesian hierarchical regression on clearance rates in the presence of "lag" and "tail" phases with an application to malaria parasites.

Fogarty CB, Fay MP, Flegg JA, Stepniewska K, Fairhurst RM, Small DS.

Biometrics. 2015 Sep;71(3):751-9. doi: 10.1111/biom.12307. Epub 2015 Apr 7.

39.

Treatment of W. bancrofti (Wb) in HIV/Wb coinfections in South India.

Talaat KR, Babu S, Menon P, Kumarasamy N, Sharma J, Arumugam J, Dhakshinamurthy K, Srinivasan R, Poongulali S, Gu W, Fay MP, Swaminathan S, Nutman TB.

PLoS Negl Trop Dis. 2015 Mar 20;9(3):e0003622. doi: 10.1371/journal.pntd.0003622. eCollection 2015 Mar.

40.

Combining one-sample confidence procedures for inference in the two-sample case.

Fay MP, Proschan MA, Brittain E.

Biometrics. 2015 Mar;71(1):146-156. doi: 10.1111/biom.12231. Epub 2014 Oct 1.

41.

Finite-sample corrected generalized estimating equation of population average treatment effects in stepped wedge cluster randomized trials.

Scott JM, deCamp A, Juraska M, Fay MP, Gilbert PB.

Stat Methods Med Res. 2017 Apr;26(2):583-597. doi: 10.1177/0962280214552092. Epub 2014 Sep 29.

42.

Effect of ingested human antibodies induced by RTS, S/AS01 malaria vaccination in children on Plasmodium falciparum oocyst formation and sporogony in mosquitoes.

Miura K, Jongert E, Deng B, Zhou L, Lusingu JP, Drakeley CJ, Fay MP, Long CA, Vekemans J.

Malar J. 2014 Jul 9;13:263. doi: 10.1186/1475-2875-13-263.

43.

Using infective mosquitoes to challenge monkeys with Plasmodium knowlesi in malaria vaccine studies.

Murphy JR, Weiss WR, Fryauff D, Dowler M, Savransky T, Stoyanov C, Muratova O, Lambert L, Orr-Gonzalez S, Zeleski KL, Hinderer J, Fay MP, Joshi G, Gwadz RW, Richie TL, Villasante EF, Richardson JH, Duffy PE, Chen J.

Malar J. 2014 Jun 3;13:215. doi: 10.1186/1475-2875-13-215.

44.

Incidence of active pulmonary tuberculosis in patients with coincident filarial and/or intestinal helminth infections followed longitudinally in South India.

Chatterjee S, Kolappan C, Subramani R, Gopi PG, Chandrasekaran V, Fay MP, Babu S, Kumaraswami V, Nutman TB.

PLoS One. 2014 Apr 11;9(4):e94603. doi: 10.1371/journal.pone.0094603. eCollection 2014.

45.

Ex-vivo cytoadherence phenotypes of Plasmodium falciparum strains from Malian children with hemoglobins A, S, and C.

Beaudry JT, Krause MA, Diakite SA, Fay MP, Joshi G, Diakite M, White NJ, Fairhurst RM.

PLoS One. 2014 Mar 19;9(3):e92185. doi: 10.1371/journal.pone.0092185. eCollection 2014.

46.

Genetics of low spinal muscular atrophy carrier frequency in sub-Saharan Africa.

Sangaré M, Hendrickson B, Sango HA, Chen K, Nofziger J, Amara A, Dutra A, Schindler AB, Guindo A, Traoré M, Harmison G, Pak E, Yaro FN, Bricceno K, Grunseich C, Chen G, Boehm M, Zukosky K, Bocoum N, Meilleur KG, Daou F, Bagayogo K, Coulibaly YI, Diakité M, Fay MP, Lee HS, Saad A, Gribaa M, Singleton AB, Maiga Y, Auh S, Landouré G, Fairhurst RM, Burnett BG, Scholl T, Fischbeck KH.

Ann Neurol. 2014 Apr;75(4):525-32. doi: 10.1002/ana.24114. Epub 2014 Apr 2.

47.

An alternative property for evaluating sample size for normal data using preliminary data.

Fay MP.

Clin Trials. 2013;10(6):990-1. doi: 10.1177/1740774513506965. No abstract available.

48.

Functional comparison of Plasmodium falciparum transmission-blocking vaccine candidates by the standard membrane-feeding assay.

Miura K, Takashima E, Deng B, Tullo G, Diouf A, Moretz SE, Nikolaeva D, Diakite M, Fairhurst RM, Fay MP, Long CA, Tsuboi T.

Infect Immun. 2013 Dec;81(12):4377-82. doi: 10.1128/IAI.01056-13. Epub 2013 Sep 16.

49.

Type 2 diabetes mellitus coincident with pulmonary tuberculosis is associated with heightened systemic type 1, type 17, and other proinflammatory cytokines.

Kumar NP, Sridhar R, Banurekha VV, Jawahar MS, Fay MP, Nutman TB, Babu S.

Ann Am Thorac Soc. 2013 Oct;10(5):441-9. doi: 10.1513/AnnalsATS.201305-112OC.

50.

Toxoplasma serotype is associated with development of ocular toxoplasmosis.

Shobab L, Pleyer U, Johnsen J, Metzner S, James ER, Torun N, Fay MP, Liesenfeld O, Grigg ME.

J Infect Dis. 2013 Nov 1;208(9):1520-8. doi: 10.1093/infdis/jit313. Epub 2013 Jul 21.

Supplemental Content

Support Center